The risk of post-endoscopic retrograde cholangiopancreatography(ERCP) pancreatitis(PEP) is influenced by patient and procedure-related factors. Strategies to decrease PEP(Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis) are of great importance.
The primary objective of this study is to provide a mechanism to store the following information about patients undergoing ERCPs at Methodist Dallas Medical Center. This registry will be permissive of quality improvement and research studies.
Study Type
OBSERVATIONAL
Enrollment
100
The registry will include all patients who meet registry inclusion. Enrollment will terminate once 25 years of data are captured: January 1, 2000 through December 31, 2025.
Methodist Dallas Medical Center- Clinical Research Institute
Dallas, Texas, United States
RECRUITINGUnderwent ERCP
Patients undergoing ERCPs at Methodist Dallas Medical Center.
Time frame: 25 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.